Comprehensive Online Course on Oncology Research and Clinical Trials

Live Online Course

Comprehensive Online Course on Oncology Research and Clinical Trials

Live Online Course

Course Leadership: Marina Puchinskaya, Anastasios Stathis and Bojana Stefanovska,

Course Overview

This course is designed for basic and translational researchers working in cancer research, eager to better understand how research is done in the clinical setting, as well as clinicians working in oncology who are interested in preclinical, translational and clinical research.
The course is aimed to connect both parties which is important for further development of cancer therapeutics and to underline the importance of understanding each other’s roles in creating better care and treatment options for cancer patients.

This comprehensive online course is designed to provide a structured overview of the entire research and clinical trial process, from basic and translational research methodology to planning and conducting clinical trials. Starting with most widespread methodologies, we will then describe more advanced techniques and further delve into principles of cancer clinical trials to give you the understanding of how modern research in oncology is organized and moved forward. The course will cover the most important aspects, including, but not limited to preclinical research methods, role of biomarkers in modern precision oncology trials, main characteristics of phase I, II and III trials and essential considerations for clinical research planning.

Learning Objectives
Upon completing this course, participants will:
  • Understand the main principles, advantages and limitations of state-of-the art techniques used for cancer diagnostics, such as pathology methods and sequencing techniques.
  • Understand the use of cellular and animal models for preclinical cancer research
  • Understand the role of biomarkers in modern research and explore strategies for integrating them into clinical trials, particularly those involving targeted therapies.
  • Improve their understanding of the phases of clinical trials, the objectives and endpoints of phase I, II and III trials, the role of preclinical research findings in clinical trials planning.
  • Understand some basic methods of statistical analysis and how statistical planning of trials is performed.
  • Learn how to conceptually plan a trial, choose appropriate endpoints and control arm, write the trial protocol using different trial design frameworks.
 
Prerequisites

This course is designed for both basic and translational researchers and clinicians to give them the unique opportunity to explore each other’s work in the pursuit of improved patients’ treatment. Participation of basic scientists interested in understanding clinical research as well as clinicians interested in combining preclinical research and clinical work is advised. A basic understanding of the discussed topics is encouraged, as well as any experience in laboratory research or clinical trials, though there are no specific prerequisites to participate in the course.

Conclusion

As you embark on this journey through modern biomedical research and clinical trial design, you will gain valuable insights that will enhance your understanding of how to plan and structure your own studies effectively in times of rapidly evolving treatment landscapes and new trial methodologies. By the end of this course, you will be equipped with the knowledge and tools necessary to understand modern research in oncology and how targets identified in preclinical research are translated to big randomized trials leading to drug approval. We look forward to guiding you through this exciting journey, with the hope of inspiring new trial ideas that will contribute to advancing treatment paradigms.

 
Course format
The course was held live online on 19 and 26 September giving participants the opportunity to engage directly with the renowned international experts and ask them questions. All lectures were recorded and are now available as part of a comprehensive course.
 
 
To access the course, participants must register

Accreditation
A certificate of attendance will be issued upon completion of:
• 75% of the online programme
• Completion of the evaluation questionnaire and learning assessment test for both parts
 
This course has been awarded 6 CME credits by the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate a maximum of 1 AMA PRA Category 1 credit per hour of activity for this type of educational program.    

ESO College
The course also enables members of the ESO College to earn credits and therefore access more membership benefits. Full and active participation in the course earns participants 3 ESO College credits.
 
Visit ESO College dedicated section for more information on membership and benefits.
 
Registration
Registration to the course is free but mandatory. Registration will be confirmed by e-mail.
 
Organising secretariat
Corinne Hall - chall@eso.net
19/09/2025 14:50

Live Streaming


19/09/2025 14:50

Welcome and Introduction

Marina Puchinskaya (BY) Bojana Stefanovska (US)

19/09/2025 15:00

Histopathology in Oncology

15:00

Morphological Characterization and Spatial Proteomics

Paolo Nuciforo (ES)
15:30

Predictive Biomarkers and AI-assisted Diagnostic

Nicola Fusco (IT)
16:00

Q&A

Nicola Fusco (IT) Paolo Nuciforo (ES)

19/09/2025 16:15

Molecular pathology in Oncology

16:15

Genomic Characterization and Advanced Molecular Technologies

Antonio Marra (IT)
16:45

Sequencing Applications, Multi-Omics, and Clinical Integration

Eloisa Jantus Lewintre (ES)
17:15

Q&A

Eloisa Jantus Lewintre (ES) Antonio Marra (IT)

19/09/2025 17:30

Model Systems for Cancer Research

17:30

Model Systems for Cancer Research

Francesco Bertoni (CH)
18:00

Q&A

Francesco Bertoni (CH) Marina Puchinskaya (BY) Bojana Stefanovska (US)

19/09/2025 18:15

Closing remarks

Marina Puchinskaya (BY) Bojana Stefanovska (US)
26/09/2025 14:50

Live Streaming


26/09/2025 14:50

Welcome and Introduction

Marina Puchinskaya (BY) Anastasios Stathis (CH) Bojana Stefanovska (US)

26/09/2025 15:00

From lab to patients: Phase I trials and biomarkers

15:00

Biomarkers in clinical trials and translational research

Christian Rolfo (US)
15:30

Phase I

Anastasios Stathis (CH)
16:00

Q&A

Christian Rolfo (US) Anastasios Stathis (CH)

26/09/2025 16:15

Later phases trials: Phase II-III trials and statistics

16:15

Phase II and III trials

Matteo Lambertini (IT)
16:45

Statistical considerations in clinical trials

Christina Yap (UK)
17:15

Q&A

Matteo Lambertini (IT) Christina Yap (UK)

26/09/2025 17:30

How to write and plan general concept of a trial protocol

17:30

How to write and plan general concept of a trial protocol

Christophe Massard (FR)
18:00

Q&A

Christophe Massard (FR)

26/09/2025 18:15

Closing remarks

Marina Puchinskaya (BY) Anastasios Stathis (CH) Bojana Stefanovska (US)
Anastasios Stathis profile photo
Anastasios Stathis

Oncology Institute of Southern Switzerland, Dept. of Medical Oncology, Bellinzona, CH

Antonio Marra profile photo
Antonio Marra

European Institute of Oncology IRCSS, Early Drug Development for Innovative Therapies, Milan, IT

Bojana Stefanovska profile photo
Bojana Stefanovska

Howard Hughes Medical Institute, Harris Lab, San Antonio, US

Christian Rolfo profile photo
Christian Rolfo

The Arthur G. James Comprehensive Cancer Center, Division of Medical Oncology, Columbus, OH, US

Christina Yap profile photo
Christina Yap

The Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU), London, UK

Christophe Massard profile photo
Christophe Massard

Gustave Roussy Institute, Department of Therapeutic Innovation and Early Stage Trials, Villejuif, FR

Eloisa Jantus Lewintre profile photo
Eloisa Jantus Lewintre

Polytechnic University of Valencia, Department of Biotechnology, Valencia, ES

Francesco Bertoni profile photo
Francesco Bertoni

IOR Institute of Oncology Research, Lymphoma & Genomics Research Program, Bellinzona, CH

Marina Puchinskaya profile photo
Marina Puchinskaya

"Kravira" Medical Centre, Surgical Department, Minsk, BY

Matteo Lambertini profile photo
Matteo Lambertini

Policlinico San Martino Hospital – University of Genoa, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, Genoa, IT

Nicola Fusco profile photo
Nicola Fusco

IRCCS European Institute of Oncology (IEO), Division of Pathology, Milan, IT

Paolo Nuciforo profile photo
Paolo Nuciforo

Vall d'Hebron Institute of Oncology (VHIO), Molecular Oncology Group, Barcelona, ES